Review Article
Review of Breast Conservation Therapy: Then and Now
Table 2
Sorlie molecular subtypes and response to neoadjuvant chemotherapy [
50,
51,
59].
| | Sorlie subtype | Receptor correlates | Estimated pCR rates |
| | Luminal A | HR+, Her2− | 7–12% | | Luminal B | HR+, Her2+ | 15–25% | | Her2-like | HR−, Her2+ | 20–25% (without Herceptin)
40–60% (with Herceptin) | | Basal | HR−, Her2− | 25–55% |
|
|
